Cenix signs research agreement with Bayer

07-May-2014 - Germany

Cenix BioScience GmbH announced that is has signed a research service agreement with Bayer Pharma AG (Bayer).

Under the agreement, Cenix will undertake a target discovery project for an undisclosed disease indication by applying its longstanding industry-leading expertise in high throughput RNAi for genome-scale screening in advanced cell models.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance